Key result
Prolonged prostaglandin E1 infusion linked to marked ductus arteriosus disruption and increased rupture risk.
Why the study?
Does prolonged prostaglandin E1 infusion cause adverse histologic changes in the patent ductus arteriosus in infants?
Population
Infants with congenital heart disease
Design
Case_series
Follow-up
Up to 39 days (at autopsy)
Authors
Loading...
Prolonged PGE1 may heighten ductus rupture risk in infants; case report leaves open need for prospective confirmation before practice change.
Case Report (n=1)
Does prolonged prostaglandin E1 infusion cause adverse histologic changes in the patent ductus arteriosus in infants?
Prolonged prostaglandin E1 infusion in infants may cause severe histologic damage to the ductus arteriosus, increasing the risk of spontaneous or surgical rupture.
Cole et al. (1981) conducted a case report in Ebstein's malformation of the tricuspid valve and severe pulmonic stenosis (n=1). Prolonged prostaglandin E1 infusion was evaluated on Histologic alterations of the ductus arteriosus. Prolonged prostaglandin E1 infusion caused marked histologic disruption and increased fragility of the ductus arteriosus, suggesting a real danger of spontaneous or surgically related rupture.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: